Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ESCC”

240 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 240 results

Large-scale testing (Phase 3)Study completedNCT03957590
What this trial is testing

Investigate Tislelizumab (BGB-A317) Versus Placebo in Combination With Concurrent Chemoradiotherapy in Participants With Localized Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
BeiGene 370
Testing effectiveness (Phase 2)UnknownNCT06055153
What this trial is testing

DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With HER2 IHC2+/3+ ESCC

Who this might be right for
Esophageal Squamous CarcinomaHER-2 Protein Overexpression
Changhai Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07196345
What this trial is testing

TAS-102 Plus Radiotherapy in Elderly ESCC

Who this might be right for
ESCCTAS 102Radiotherapy
Qianfoshan Hospital 45
Early research (Phase 1)Study completedNCT03518554
What this trial is testing

A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung CancerHead and Neck CancerEsophageal Cancer+1 more
Jacobio Pharmaceuticals Co., Ltd. 38
Not applicableLooking for participantsNCT07549100
What this trial is testing

Efficacy and Safety of Tislelizumab Plus Chemotherapy as Conversion Therapy in Unresectable Locally Advanced ESCC

Who this might be right for
Locally Advanced Esophageal Squamous Cell Carcinoma
Shandong Provincial Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06601309
What this trial is testing

Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fujian Medical University Union Hospital 90
Not applicableUnknownNCT03831828
What this trial is testing

Correlation of Gene Status and Clinical Outcomes in ESCC

Who this might be right for
Prognosis of Patients With ESCC
LiuJunFeng 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07584031
What this trial is testing

Adebrelimab Plus Full-course Neoadjuvant Therapy for Resectable Locally Advanced ESCC (Phase 2)

Who this might be right for
ESCC
Tianjin Medical University Cancer Institute and Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT06339619
What this trial is testing

Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 32
Early research (Phase 1)Not Yet RecruitingNCT07203898
What this trial is testing

IPM514 in Patients With Esophageal Squamous Cell Carcinoma.

Who this might be right for
Esophageal Squamous Cell Carcinoma
Beijing Immupeutics Medicine Technology Limited 36
Large-scale testing (Phase 3)UnknownNCT05213312
What this trial is testing

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 90
Large-scale testing (Phase 3)Looking for participantsNCT06354530
What this trial is testing

Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Neoadjuvant TherapyEsophageal Squamous Cell Carcinoma
Army Medical Center of PLA 266
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06861894
What this trial is testing

Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhigang Li 164
Large-scale testing (Phase 3)Looking for participantsNCT04807673
What this trial is testing

Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 342
Early research (Phase 1)Study completedNCT01822613
What this trial is testing

Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Novartis Pharmaceuticals 48
Not applicableStudy completedNCT07549269
What this trial is testing

Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted Analysis

Who this might be right for
Esophageal Cancer
Sichuan University 387
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07524374
What this trial is testing

SHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After Immunotherapy

Who this might be right for
ESCC
Zhigang Li 33
Testing effectiveness (Phase 2)Study completedNCT04548440
What this trial is testing

Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-Sen University Cancer Center 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07533305
What this trial is testing

Efficacy and Safety of QL1706 Combined With Nab-paclitaxel and Cisplatin as 1st Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
QL1706ESCCFirst-line Therapy
The First Affiliated Hospital of Henan University of Science and Technology 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06888531
What this trial is testing

Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Malignant Neoplasm Primary
Henan Cancer Hospital 30
Load More Results